EBS
Emergent Biosolutions Inc
6.80$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 | 0.62 | -1.20 | 0.90 | 2.76 | -1.47 | -0.20 | 1.96 | -0.04 | 1.48 | -0.60 | 1.09 | 1.89 | |
| 0.54 | 0.57 | 0.53 | 0.54 | 0.47 | 0.48 | 0.44 | 0.43 | 0.41 | 0.45 | 0.42 | 0.47 | 1.83 | |
| 0.08 | 0.08 | 0.11 | 0.10 | 0.04 | 0.08 | 0.03 | 0.08 | 0.08 | 0.10 | 0.03 | 0.13 | 0.37 | |
| 4.40 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.27 | 0.90 | -1.87 | 3.91 | 1.18 | -1.57 | -2.07 | 1.77 | -1.44 | 1.56 | -0.92 | -0.48 | -1.47 | |
| 0.24 | 0.22 | 0.21 | 0.09 | 0.10 | 0.03 | 0.06 | 0.05 | 0.06 | 0.07 | 0.04 | 0.04 | 0.23 | |
| -0.36 | -0.22 | -0.21 | -0.09 | 2.01 | 0.53 | 1.04 | 0.32 | -0.06 | -0.07 | -0.04 | -1.01 | -1.20 | |
| 0.04 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.00 | 0.00 | -0.01 | 0.00 | 0.01 | 0.45 | 0.00 | -0.13 | -0.16 | -0.17 | -0.16 | -0.17 | -0.70 | |
| -0.83 | – | – | – | -3.49 | 0.00 | 0.00 | 0.00 | -0.12 | -1.94 | – | – | – | |
| -0.83 | 0.09 | 0.78 | -0.97 | -3.24 | 0.01 | -0.01 | -0.12 | -0.28 | -2.17 | -0.20 | -0.47 | -3.21 | |
| -0.02 | 0.46 | -0.63 | -0.15 | 1.54 | -0.94 | 0.82 | 2.18 | -0.39 | -0.77 | -0.84 | -0.40 | -2.52 | |
| 0.92 | 0.40 | -1.41 | 0.82 | 2.66 | -1.51 | -0.26 | 1.91 | -0.10 | 1.41 | -0.64 | 1.05 | 1.66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.